The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Treatment-resistant depression refers to major depressive disorder, treatment of the disorder, and failure to obtain an "acceptable" outcome. Regarding the disorder, the heterogeneous concept of major depressive disorder and the multiple definitions of treatment-resistant depression, hesitating between a categorical and a more dimensional approach, as well as the divergence between diagnostic criteria and the items in the assessment scales are a source of confusion. Classifications do not take into account the dramatic influence of patient characteristics strongly impacting outcome, although these can be the cause of so-called pseudo-resistance. Outcome is the result of spontaneous evolution, nonspecific factors (including placebo), and active treatment factors. These should be differentiated to have a reliable estimation of the impact of different treatment modalities before we can asses treatment-resistant depression or before we can ascertain the (non)efficacy of treatments for treatment-resistant depression.The impact and burden of major depressive disorder and treatment-resistant depression are immense and go far beyond their economic cost. It is often forgotten that both are not only associated with increased suicidality but also with nonsuicidal mortality and that both can even result in requests for assisted dying. The caregiver burden and associated stigma are also too often overlooked despite that it has been suggested that they do influence (treatment) outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“None of the extant TRD definitions are universally accepted and/or implemented at point- of- care in clinical practice 11,32,64- 68 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The foregoing cascade approach - which in tegrates aspects of misdiagnosis, non- ad herence, inadequate treatment trials, as well as implementation gaps - underscores the high prevalence of poor outcomes of depression in primary care, of which a significant percentage would be expected to meet crite ria for TRD 10,30,64,71,107,108 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,380
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“The standard definition of response and remission is 50% improvement from baseline and 3 weeks with virtual absence of depressive symptoms, respectively (Frank et al., 1991).”
BackgroundThe Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
The economic cost of brain disorders in Europe
Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H. ‐., Jönsson, B., on behalf of the CDBE2010 study group, & the European Brain Council (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03590.x · Cited by 1,481
Fried, E. I., & Nesse, R. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.010 · Cited by 1,043
van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G. P., Ormel, J., van Veldhuisen, D. J., van den Brink, R. H. S., & van den Berg, M. P. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146294.82810.9c · Cited by 1,034
The inventory for depressive symptomatology (IDS): Preliminary findings
John Rush, A., Giles, D. E., Schlesser, M. A., Fulton, C. L., Weissenburger, J., & Burns, C. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90060-0 · Cited by 918
Research works printed but not linked: 1
- World Health Organization, 2017, Depression and other common mental disorders: global health estimates
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationSackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., Demitrack, M. A., George, M. S., Prudic, J., Thase, M. E., & Rush, A. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.021 · Cited by 109
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94
“ing treatments are generally considered effective [5], treatment-resistance is a common and increasing clinical phenomenon [6,7].”
BackgroundSheikhan, N. Y., Henderson, J. L., Halsall, T., Daley, M., Brownell, S., Shah, J. L., Iyer, S. N., & Hawke, L. D. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09075-6 · Cited by 83
Economic impact of treatment-resistant depression: A retrospective observational study
Pérez-Sola, V., Roca, M., Alonso, J., Gabilondo, A., Hernando, T., Sicras-Mainar, A., Sicras-Navarro, A., Herrera, B., & Vieta, E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.036 · Cited by 55
The impact of ATP-binding cassette transporters in the diseased brain: Context matters
Baltira, C., Aronica, E., Elmquist, W. F., Langer, O., Löscher, W., Sarkaria, J. N., Wesseling, P., de Gooijer, M. C., & van Tellingen, O. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101609 · Cited by 60
Editorial: Treatment resistant depression (TRD): epidemiology, clinic, burden and treatment
Fiorillo, A., Demyttenaere, K., Martiadis, V., & Martinotti, G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1588902 · Cited by 49
Self-citationPardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51
van Veen, S. M. P., Ruissen, A. M., & Widdershoven, G. A. M. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720923072 · Cited by 57
“First, the current psychiatric diagnostic model is said to describe syndromes and therefore offers no insight in the underlying biological, psychodynamic, or social factors, hampering the possibility of accurate prediction of disease progression.(9,14,28,30,40) Second, psychiatric disorders themselves are said not to…”
BackgroundGarel, N., Drury, J., Lévesque, J. T., Goyette, N., Lehmann, A., Looper, K. J., Erritzøe, D., Dames, S., Turecki, G., Rej, S., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1268832 · Cited by 40
Psychiatric Practice Patterns and Barriers to the Adoption of Esketamine
Wilkinson, S. T., Howard, D. H., & Busch, S. H. (2019) · JAMA · doi:10.1001/jama.2019.10728 · Cited by 35
Pathophysiology of Major Depression by Clinical Stages
de Menezes Galvão, A. C., Almeida, R. N., de Sousa, G. M., Leocadio-Miguel, M. A., Palhano-Fontes, F., de Araujo, D. B., Lobão-Soares, B., Maia-de-Oliveira, J. P., Nunes, E. A., Hallak, J. E. C., et al. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.641779 · Cited by 31
Irremediability in psychiatric euthanasia: examining the objective standard
Nicolini, M. E., Jardas, E., Zarate, C. A., Gastmans, C., & Kim, S. Y. H. (2023) · Psychological Medicine · doi:10.1017/s0033291722002951 · Cited by 31
Treatment-resistant bipolar depression: concepts and challenges for novel interventions
Díaz, A. P., Fernandes, B. S., Quevedo, J., Sanches, M., & Soares, J. C. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1627 · Cited by 42
What is treatment resistance in psychiatry? A “difficult to treat” concept
Demyttenaere, K. (2019) · World Psychiatry · doi:10.1002/wps.20677 · Cited by 27
Self-citationTreatment of difficult-to-treat depression – clinical guideline for selected interventions
Møeller, S. B., Gbyl, K., Hjorthøj, C. R., Andreasen, M., Austin, S. F., Buchholtz, P. E., Fønss, L., Hjerrild, S., Hogervorst, L., Jørgensen, M. B., et al. (2021) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2021.1952303 · Cited by 32
Stanford neuromodulation therapy for treatment-resistant depression: a systematic review
Lan, X.-J., Cai, D.-B., Liu, Q.-M., Qin, Z.-J., PRIDMORE, S. A., Zheng, W., & Xiang, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1290364 · Cited by 31
Chen, M., Lin, W.-C., Tsai, S., Li, C., Cheng, C., Wu, H.-J., Bai, Y., Hong, C., Tu, P., & Su, T. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01264-w · Cited by 25
Irremediable psychiatric suffering in the context of medical assistance in dying: A delphi-study
van Veen, S. M. P., Evans, N., Ruissen, A. M., Vandenberghe, J., Beekman, A. T. F., & Widdershoven, G. A. M. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221087052 · Cited by 21
The complexity of treatment-resistant depression: A data-driven approach
Rost, F., Booker, T., Gonsard, A., de Felice, G., Asseburg, L., Castillo, J. M., Koutoufa, I., Ridsdale, H., Johnson, R., Taylor, D., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.093 · Cited by 26
Giacobbe, P., Mithani, K., Meng, Y., Vila‐Rodriguez, F., Daskalakis, Z. J., Downar, J. H., & Blumberger, D. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.002 · Cited by 26
The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
Wilkowska, A., & Cubała, W. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314605 · Cited by 22
Gkesoglou, T., Bargiota, S. I., Iordanidou, E., Vasiliadis, M., Bozikas, V., & Agorastos, A. (2022) · Brain Sciences · doi:10.3390/brainsci12070940 · Cited by 20
Elias, G. J. B., Germann, J., Boutet, A., Beyn, M. E., Giacobbe, P., Song, H. N., Choi, K. S., Mayberg, H. S., Kennedy, S. H., & Lozano, A. M. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.08.014 · Cited by 22
Optimized Treatment Strategy for Depressive Disorder
Chen, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_11 · Cited by 23
The prevalence and economic burden of treatment-resistant depression in Thailand
Prasartpornsirichoke, J., Pityaratstian, N., Poolvoralaks, C., Sirinimnualkul, N., Ormtavesub, T., Hiranwattana, N., Phonsit, S., & Rungnirundorn, T. (2023) · BMC Public Health · doi:10.1186/s12889-023-16477-y · Cited by 19
Tu, P., Chang, W.-C., Su, T., Lin, W.-C., Li, C., Bai, Y., Tsai, S., & Chen, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02640-3 · Cited by 20
Chen, M., Lin, W.-C., Li, C., Tsai, S., Wu, H.-J., Bai, Y., Hong, C., Tu, P., & Su, T. (2021) · Pharmacopsychiatry · doi:10.1055/a-1589-6301 · Cited by 16
Ketamine: Leading us into the future for development of antidepressants
Carreno, F. R., Lodge, D. J., & Frazer, A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112532 · Cited by 16
Could ketamine be the answer to treating treatment‐resistant major depressive disorder?
Ramadan, A., & Mansour, I. (2020) · General Psychiatry · doi:10.1136/gpsych-2020-100227 · Cited by 20
Furukawa, Y., Oguro, S., Obata, S., Hamza, T., Ostinelli, E. G., & Kasai, K. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13438 · Cited by 14
miRNAs in treatment-resistant depression: a systematic review
Cai, L., Xu, J., Liu, J., Luo, H., Yang, R., Gui, X., & Wei, L. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09554-x · Cited by 15
Chen, L.-C., Chen, M., Bai, Y., Chen, T.-J., & Su, T. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000574 · Cited by 23
Lin, W., Su, T., Li, C., Wu, H.-J., Bai, Y., Liu, Y., Tu, P., & Chen, M. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad045 · Cited by 16
Difficult-To-Treat Depression. Scoping Review.
Paganin, W., Signorini, S. G., & Sciarretta, A. (2023) · PubMed Central · doi:10.36131/cnfioritieditore20230302 · Cited by 28
Sackeïm, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., George, M. S., McAllister-Williams, H., Prudic, J., Thase, M. E., Young, A. H., & Rush, A. J. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.05.046 · Cited by 17
Wang, Y., Li, S., Niu, L., Ma, Y., Qiu, Y., Li, S., Guobule, N., Cao, H., & Li, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02415-y · Cited by 14
Economic evaluation of interventions for treatment-resistant depression: A systematic review
Hannah, L. A., Walsh, C., Jopling, L. A., Pérez, J. M., Cardinal, R. N., & Cameron, R. A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1056210 · Cited by 16
Paganin, W. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2448 · Cited by 15
Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts
Bessa, J. M., Carvalho, S., Cunha, I. B., Fernandes, M., Matos-Pires, A., Neves, R., Oliveira-Maia, A. J., Santos, S. G., & Santos, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.824919 · Cited by 16
Chen, M., Cheng, C., Li, C., Tsai, S., Lin, W., Bai, Y., & Su, T. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114749 · Cited by 13
Immune Dysregulation in Treatment-Resistant Depression
Fatt, C. C., Mayes, T. L., & Trivedi, M. H. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.02.010 · Cited by 9
Moyano, B. P., Orgeta, V., von Gunten, A., Vandel, P., Ma, R., Stewart, R. J., & Mueller, C. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.169 · Cited by 12
McPherson, S., & Senra, H. (2022) · Psychotherapy · doi:10.1037/pst0000448 · Cited by 11
Editorial for Treatment-Resistant Depression (TRD)
Kasper, S. F., & Frazer, A. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz006 · Cited by 10
Statins in depression: a repurposed medical treatment can provide novel insights in mental health
Giorgi, R. D., Cowen, P. J., & Harmer, C. J. (2022) · International Review of Psychiatry · doi:10.1080/09540261.2022.2113369 · Cited by 10
Yanguela, J., Pence, B. W., Udedi, M. M., Banda, J. C., Kulisewa, K., Zimba, C. C., Malava, J., Akiba, C. F., Dussault, J. M., Morrison, A. M., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00597-1 · Cited by 12
Chen, M., Lin, W.-C., Wu, H.-J., Bai, Y., Li, C., Tsai, S., Hong, C., Tu, P., & Su, T. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05737-z · Cited by 9
Chen, M., Wu, H.-J., Li, C., Lin, W., Tsai, S., Hong, C., Tu, P., Bai, Y., Mao, W., & Su, T. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.006 · Cited by 9
Huang, W., Chiang, C. N., Wu, C., Liao, S., Chien, T. H., Tseng, C.-H., & Tang, C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.114 · Cited by 7
Arendt, I. T. P., Gondan, M., Juul, S., Hastrup, L. H., Hjorthøj, C. R., Bach, B., Videbech, P., Jørgensen, M. B., & Møeller, S. B. (2024) · Trials · doi:10.1186/s13063-024-08079-9 · Cited by 9
Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression
Moyano, B. P., Zullo, L., Rouaud, O., Vandel, P., von Gunten, A., & Allali, G. (2024) · Neurodegenerative Diseases · doi:10.1159/000541783 · Cited by 7
Lyons, M. A., & Delgadillo, J. (2024) · British Journal of Clinical Psychology · doi:10.1111/bjc.12513 · Cited by 10
von Mücke-Heim, I.-A., Pape, J. C., Grandi, N. C., Erhardt, A., Deussing, J. M., & Binder, E. B. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01647-1 · Cited by 7
Early or recent trauma in treatment-resistant depression: a systematic review
Fantasia, S., Conti, L., Andreoli, D., Bordacchini, A., Rimoldi, B., Dell’Oste, V., Pedrinelli, V., & Carmassi, C. (2025) · CNS Spectrums · doi:10.1017/s1092852925000185 · Cited by 10
Ji, I. S., Cheng, M. C. H., Teopiz, K. M., Dri, C. E., Wong, S., Le, G. H., Rhee, T. G., Guillen-Burgos, H. F., Lo, H. K. Y., Zheng, Y. J., et al. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.10.056 · Cited by 8
Bonetto, G. G., Corral, R. M., Lupo, C., Vilapriño, M., Alessandria, H., KANEVSKY, G. A., & Cabrera, P. (2022) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v33i155.134 · Cited by 10
Cosmo, C. S. A., Berlow, Y. A., Grisanzio, K. A., Fleming, S. L., Ahmed, A. P. R., Brennan, M. C., Carpenter, L. L., & Philip, N. S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020224 · Cited by 6
Chen, M., Wu, H.-J., Li, C., Lin, W., Tsai, S., Hong, C., Tu, P., Bai, Y., Mao, W., & Su, T. (2021) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2820 · Cited by 5
Bisconti, N., Odier, M., Becker, M. A., & Bullock, K. D. (2024) · JMIR Mental Health · doi:10.2196/52369 · Cited by 4
Paganin, W. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1484440 · Cited by 7
Porceddu, G., Pessina, E., Cattaneo, C. I., Martiadis, V., Bianca, C., Maina, G., & Rosso, G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1744056 · Cited by 2
Rethinking the Treatment-Resistant Depression
Tan, Y., & Hashimoto, K. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_5 · Cited by 2
Recco, K. C. C., Bonetto, G. G., Lupo, C., Nardi, A. E., Morales, A., Becerra‐Palars, C., Perocco, S., & Pfau, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1221746 · Cited by 2
de Miranda, A. S., Toscano, E. C. D. B., Venna, V. R., Graeff, F. G., & Teixeira, A. L. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2460674 · Cited by 4
Perspectives on Personalized Treatment in Difficult‐to‐Treat Depression: A Case Report
Paganin, W., & Signorini, S. (2025) · Case Reports in Psychiatry · doi:10.1155/crps/5538951 · Cited by 4
The economic burden of treatment-resistant depression: Cost-of-illness perspective
Niazi, S. K., & Bobo, W. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00003-7 · Cited by 3
Unmet Needs in the Treatment of Personality Disorders
Paris, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_6 · Cited by 4
Jiang, H., Zhang, J., Li, Q., & Zhou, Y. (2024) · Medicine · doi:10.1097/md.0000000000039726 · Cited by 2
Aljabali, A. A. A., Alkaraki, A. K., Gammoh, O., Qnais, E. Y., Alqudah, A. M., Alshaer, W., Mishra, V. K., Mishra, Y., & El‐Tanani, M. (2025) · Current Clinical Pharmacology · doi:10.2174/0127724328381443250825092900 · Cited by 1
Brain stimulation for treatment-resistant depression
Rodrigues, A., Martins, L., Villela, N. R., Razza, L. B., & Brunoni, A. R. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.03.006 · Cited by 1
Impact of antimicrobial resistance on health and economy: A comprehensive review
(2023) · Biomedical Letters · doi:10.47262/bl/9.1.20230417 · Cited by 1
Chen, M., & Tsai, S. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111242 · Cited by 2
Schreyer, L., Kalocsai, C., Fernando, O., Anderson, M., Lockwood, V., Soklaridis, S., Remington, G. J., Chintoh, A. F., & Berkhout, S. (2024) · SSM - Mental Health · doi:10.1016/j.ssmmh.2024.100350 · Cited by 1
Nakazawa, A., Matsuda, Y., Yamazaki, R., Taruishi, N., & Kito, S. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12494 · Cited by 4
Intranasal esketamine in treatment-resistant depression: a profile of its use
Scott, L. J. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00675-z · Cited by 1
Carreno, F. R., & Frazer, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00044-x · Cited by 1
Blick in internationale Zeitschriften
Doering, S. (2019) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2019.65.2.212
Dépression résistante aux traitements
Vlaicu, M. B. ̆., & Vlaicu, A. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77862-9.00005-0
Economic Evaluation of Mental Health Interventions
Jin, H., Jalali, A., Wijnen, B. F. M., & Bao, Y. (2023) · Frontiers research topics · doi:10.3389/978-2-8325-3692-6
Incidence of treatment-resistant depression during the first mood depressive episode.
Said, M., Hosni, R., Jemli, H., Zgueb, Y., Ouali, U., Zalila, H., Nacef, F., & Jomli, R. (2023) · PubMed Central
Maier, H. B., Borchert, A., Neyazi, A., Moschny, N., Schülke, R., Bundies, G. L., Folsche, T., Gaspert, A., Seifert, J., Bleich, S., et al. (2024) · Pharmacopsychiatry · doi:10.1055/a-2292-1438
Determining the Level of Depression Stigma of University Students: A Descriptive Study
Atay, E., Olgun, N., & Boztepe, Z. (2024) · Doğu Karadeniz Sağlık Bilimleri Dergisi · doi:10.59312/ebshealth.1462815
Cheng, L., Chen, L., Su, T., Li, C., Lin, W., Tsai, S., Bai, Y., Tu, P., & Chen, M. (2025) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2025.100292
Hương, P. T. T., Wu, C., Lee, M., Tuan, N. V., Hien, P. T. T., Anh, N. T. L., Son, N. T., & Hien, N. T. T. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1597196 · Cited by 2
Arendt, I.-M. T. P., Gondan, M., Juul, S., Hastrup, L. H., Hjorthøj, C. R., Bach, B., Videbech, P., Jørgensen, M. B., & Møeller, S. B. (2024) · Figshare · doi:10.6084/m9.figshare.26707769
Arendt, I.-M. T. P., Gondan, M., Juul, S., Hastrup, L. H., Hjorthøj, C., Bach, B., Videbech, P., Jørgensen, M. B., & Møeller, S. B. (2024) · Figshare · doi:10.6084/m9.figshare.25621913
Arendt, I.-M. T. P., Gondan, M., Juul, S., Hastrup, L. H., Hjorthøj, C. R., Bach, B., Videbech, P., Jørgensen, M. B., & Møeller, S. B. (2024) · Figshare · doi:10.6084/m9.figshare.26707763
Arendt, I.-M. T. P., Gondan, M., Juul, S., Hastrup, L. H., Hjorthøj, C. R., Bach, B., Videbech, P., Jørgensen, M. B., & Møeller, S. B. (2024) · Figshare · doi:10.6084/m9.figshare.26707766
Arendt, I.-M. T. P., Gondan, M., Juul, S., Hastrup, L. H., Hjorthøj, C. R., Bach, B., Videbech, P., Jørgensen, M. B., & Møeller, S. B. (2024) · Figshare · doi:10.6084/m9.figshare.25622121
Arendt, I.-M. T. P., Gondan, M., Juul, S., Hastrup, L. H., Hjorthøj, C. R., Bach, B., Videbech, P., Jørgensen, M. B., & Møeller, S. B. (2024) · Figshare · doi:10.6084/m9.figshare.26707760
Antoniou, A., Pappa, S., Dikeos, D., Smyrnis, N., Mendlevicz, J., Serretti, A., Cleare, A. J., & Ferentinos, P. P. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1769246 · Cited by 1
Cognitive effects of intravenous Ketamine in treatment-resistant depression: A systematic review
Chavigny, L.-A., Jodoin, V. D., Garel, N., Ndongo, M. S., Osborne, L., Turecki, G., & Devantoy, S. R. (2026) · Psychological Medicine · doi:10.1017/s0033291726103961
Chapter 4. The Myth of Treatment Resistance?
(2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551937.lg04
McCullough, J. P., & Long, L. R. (2026) · Cognitive Therapy and Research · doi:10.1007/s10608-026-10736-z
Ali, M. A. S., Amirthalingam, P., Alshareef, H. M., Alassiry, M. Z., Elshenawy, A. S., Mansour, S. H. E.-D., & Aljabri, A. M. (2026) · Healthcare · doi:10.3390/healthcare14172717
Metadata
- Authors
- Demyttenaere, K., & Van Duppen, Z.
- Affiliations
- KU Leuven (BE)
- University Psychiatric Center KU Leuven, Campus Kortenberg
- Corresponding author
- Demyttenaere, Koen
- ORCID
- Demyttenaere, Koen
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-28
- Volume
- 22
- Issue
- 2
- Pages
- 85-92
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC6368367
- OpenAlex
- W2809990157
- Cited by
- 98
- References
- 75
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 25 · 2023: 19 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 7
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Lirias (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, major depressive disorder, diagnostic criteria, pseudoresistance, treatment outcomes, placebo effect, suicidality, assisted dying, caregiver burden, stigma
- MeSH terms
- Major Depressive Disorder, Humans, Cost of Illness, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.